{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:06:03Z","timestamp":1789909563983,"version":"4.0.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/olq.0b013e3181f68ebb","type":"journal-article","created":{"date-parts":[[2010,10,9]],"date-time":"2010-10-09T07:06:35Z","timestamp":1286607995000},"page":"216-218","source":"Crossref","is-referenced-by-count":59,"title":["Efficacy and Safety of Imiquimod Versus Podophyllotoxin in the Treatment of Anogenital Warts"],"prefix":"10.1097","volume":"38","author":[{"given":"Peter","family":"Komericki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Akkilic-Materna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Strimitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Aberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210213","first-page":"1","article-title":"Centers for Disease Control and Prevention.","volume":"51","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"R2-13-20210213","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00007435-200111000-00006","article-title":"Condylomata acuminate (genital warts): Patient demographics and treating physicians.","volume":"28","author":"Fleischer","year":"2001","journal-title":"Sex Transm Dis"},{"key":"R3-13-20210213","first-page":"5","article-title":"An evidence-based review of medical and surgical treatments of genital warts.","volume":"12","author":"Scheinfeld","year":"2006","journal-title":"Dermatol Online J"},{"key":"R4-13-20210213","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0002-9343(97)00181-2","article-title":"Therapeutic approaches to genital warts.","volume":"102","author":"Beutner","year":"1997","journal-title":"Am J Med"},{"key":"R5-13-20210213","first-page":"388","article-title":"Condylomata acuminate.","volume":"94","author":"Kaplan","year":"1942","journal-title":"New Orleans Med Surg J"},{"key":"R6-13-20210213","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00510353","article-title":"Cutaneous cytodestructive potency of lignans. A comparative evaluation of influence on epidermal and dermal DNA synthesis and on dermal microcirculation in the hairless mouse.","volume":"274","author":"Von","year":"1982","journal-title":"Arch Dermatol Res"},{"key":"R7-13-20210213","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00007435-198107000-00002","article-title":"Penile condylomata acuminata: An experimental model for evaluation of topical self-treatment with 0.5%\u20131% ethanolic preparations of podophyllotoxin for 3 days.","volume":"8","author":"Von Krogh","year":"1981","journal-title":"Sex Transm Dis"},{"key":"R8-13-20210213","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/sti.79.4.270","article-title":"Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts.","volume":"79","author":"Lacey","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R9-13-20210213","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.134.1.33","article-title":"Safety and efficacy of 0.5% podofilox gel in the treatment of angenital warts.","volume":"134","author":"Tyring","year":"1998","journal-title":"Arch Dermatol"},{"key":"R10-13-20210213","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00007435-199205000-00012","article-title":"Self-treatment using a 0.5% podophyllotoxin cream of external genital condylomata acuminata in women: A placebo-controlled, double-blind study.","volume":"19","author":"Von Krogh","year":"1992","journal-title":"Sex Transm Dis"},{"key":"R11-13-20210213","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000246818","article-title":"Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of condylomata acuminata in women: A placebo-controlled, double-blind study.","volume":"189","author":"Sayed","year":"1994","journal-title":"Dermatology"},{"key":"R12-13-20210213","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.42.4.789","article-title":"Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.","volume":"42","author":"Beutner","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-13-20210213","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/OLQ.0b013e31815ea8d1","article-title":"Optimal frequency of imiquimod (Aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: A meta-analysis.","volume":"35","author":"Gotovtseva","year":"2008","journal-title":"Sex Transm Dis"},{"key":"R14-13-20210213","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0190-9622(98)70243-9","article-title":"Treatment of genital warts with an immune-response modifier (imiquimod).","volume":"38","author":"Beutner","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"R15-13-20210213","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group: Human Papillomavirus.","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"R16-13-20210213","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1346-8138.2004.tb00568.x","article-title":"Topical imiquimod 5% cream in external anogenital warts: A randomized double-blind, placebo-controlled study.","volume":"31","author":"Arican","year":"2004","journal-title":"J Dermatol"},{"key":"R17-13-20210213","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000095039","article-title":"Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata.","volume":"213","author":"Yan","year":"2006","journal-title":"Dermatology"},{"key":"R18-13-20210213","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(87)91823-X","article-title":"Comparison of podophyllotoxin and podophyllin in the treatment of genital warts.","volume":"2","author":"Lassus","year":"1987","journal-title":"Lancet"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007435-201103000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:39:37Z","timestamp":1786041577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007435-201103000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e3181f68ebb","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}